A recent report based on a series of studies suggests that acetominopen might contribute to the development of childhood asthma.  Obviously, this is a major discovery as acetominopen is the most popular anti-pyretic and anti-analgesic in the pediatric population.  You can read the full New York Times report by Clicking Here